Tech Company Financing Transactions
Tamarind Bio Funding Round
Tamarind Bio, based in San Francisco, secured $13.6 million in investment from Dimension and private investors.
Transaction Overview
Company Name
Announced On
2/24/2026
Transaction Type
Venture Equity
Amount
$13,600,000
Round
Series A
Investors
Dimension (Lead Investor) (Nan Li)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
90 New Montgomery St 1301
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Overview
At Tamarind, we provide web interfaces and APIs for the leading publicly available molecular design tools. Users can run models like AlphaFold/Chai-1, RFdiffusion, ProteinMPNN and 200+ others with up to hundreds of thousands of inputs running in parallel. Customers, including many top 20 biopharma, use us to design de novo binders, stabilize/solubilize antigens, improve binding affinities of protein binders, and score Abs for developability.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Deniz Kavi
Co-Founder
Sherry Liu
Browse more venture capital transactions:
Prev: 2/24/2026: Handl Health venture capital transaction
Next: 2/24/2026: Turbine AI venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs